News Releases

Engineering Cancer’s End: Moffitt Scientists Say Bioengineering Will Change Our Ability to Research and Treat Cancer

Commentary in Cancer Cell discusses why this area of science is the future

Innovative Combination Therapy Shows Promise for Bladder Cancer Patients Unresponsive to Standard Treatment

CORE-001 trial demonstrates efficacy of oncolytic virus and immune checkpoint inhibitor in treating non-muscle invasive bladder cancer

Moffitt Cancer Center and Virogen Biotechnology Forge Groundbreaking Partnership to Accelerate Oncology and Immunotherapy Innovations

Collaboration to expedite development of revolutionary fusion protein VG712 enhances treatment options for cancer patients and advances immunotherapy...

Moffitt Cancer Center Uses AI to Develop More Personalized Cancer Treatment Strategies

Innovative study harnesses deep reinforcement learning to tailor adaptive treatment schedules for metastatic prostate cancer, doubling time to...

Joanna Weiss Appointed Moffitt’s Chief Financial Officer

She will oversee all financial operations for the cancer center

Moffitt Cancer Center and Fulgent Pharma Join Forces To Revolutionize Cancer Therapeutics

Collaboration aims to accelerate the development of personalized therapies and transform patient care through the use of precision medicine

Oncology Nursing Certification Corporation Employer Recognition Award Goes to Moffitt

This is the cancer center’s second time being recognized

Moffitt Initiates Groundbreaking Clinical Trial with Oncolytic Virus for Non-Small Cell Lung Cancer

The phase 1 trial is evaluating MEM-288 in combination with nivolumab

Moffitt Study Suggests Cells Possess Hidden Communication System

New research finds ion gradients across membranes form an information network for rapid cellular decision-making independent of DNA

Moffitt Researchers Discover New Therapeutic Target for Non-Small Cell Lung Cancer

Disrupting Jagged2 signaling reprograms immune cells to fight tumors

Moffitt Treats First Clinical Trial Patient with Gamma Delta CAR T for Bone Metastatic Prostate Cancer

The single-center, phase 1 dose-escalation trial targets the prostate stem cell antigen highly expressed in this disease

Registration Open for 2024 Miles for Moffitt Presented by AutoNation

Moffitt Cancer Center aims to raise $1.7 million for innovative cancer research

Moffitt Cancer Center to Revolutionize Cancer Care Delivery Using AI and Machine Learning with NVIDIA, Oracle and Deloitte

Collaboration aims to develop natural language processing models that can streamline clinical workflows, improve documentation accuracy and enhance...

Moffitt Cancer Center Recognized as a Tampa Bay Times Top Workplace for 13th Time

The cancer center recognizes its team members for the critical role they play in the organization’s success

Ken Jones Appointed to Moffitt Cancer Center’s Institute Board of Directors

He is the designee of Brian Lamb, chair of Florida’s Board of Governors